Standardized approach to idiopathic retroperitoneal fibrosis: a comprehensive review of the literature

References

• Ormond JK. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol. 1948;59:1072–1079.
   Google Scholar
• van Bommel EF, Jansen I, Hendriksz TR, et al. Idiopathic retroperitoneal fibrosis: prospective evaluation of incidence and clinicoradiologic presentation. Medicine (Baltimore). 2009;88:193–201.
   Google Scholar
• Scheel PJ Jr, Feeley N. Retroperitoneal fibrosis. Rheumatol Dis Clin N Am. 2013;39:365–381.
   Google Scholar
• Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006;55:126–130.
   Google Scholar
• Goldoni M, Bonini S, Urban ML, et al. Asbestos and smoking as risk factors for idiopathic retroperitoneal fibrosis: a case-control study. Ann Intern Med. 2014;161:181–188.
   Google Scholar
• Rossi GM, Rocco R, Accorsi Buttini E, et al. Idiopathic retroperitoneal fibrosis and its overlap with IgG4-related disease. Intern Emerg Med. 2017;12:287–299.
   Google Scholar
• Khosroshahi A, Carruthers MN, Stone JH, et al. Rethinking Ormond’s disease: “idiopathic” retroperitoneal fibrosis in the era of IgG4-related disease. Medicine (Baltimore). 2013;92:82–91.
   Google Scholar
• Kamisawa T, Zen Y, Pillai S, et al. IgG4-related disease. Lancet. 2015;385:1460–1471.
   Google Scholar
• Vaglio A, Maritati F. Idiopathic retroperitoneal fibrosis. J Am Soc Nephrol. 2016;27:1880–1889.
   Google Scholar
• Lipton S, Schwab P. Neoplasm mimics of rheumatologic presentations: sialadenitis, ocular masquerade syndromes, retroperitoneal fibrosis, and regional pain syndromes. Rheumatol Dis Clin N Am. 2011;37:623–637.
   Google Scholar
• Alberti C. Drug-induced retroperitoneal fibrosis: short aetiopathogenetic note, from the past times of ergot-derivatives large use to currently applied bio-pharmacology. G Chir. 2015;36:187–191.
   Google Scholar
• Rousselina C, Pontanaa F, Puecha P, et al. Diagnostics différentiels des aortites inflammatoires. Rev Méd Int. 2016;37:256–263.
   Google Scholar
• Parums DV, Brown DL, Mitchinson MJ. Serum antibodies to oxidized low-density lipo-protein and ceroid in chronic periaortitis. Arch Pathol Lab Med. 1990;114:383–387.
   Google Scholar
• Martorana D, Vaglio A, Greco P, et al. Chronic periaortitis and HLA-DRB1*03: another clue to an autoimmune origin. Arthritis Rheum. 2006;55:126–130.
   Google Scholar
• Yachoui R, Sehgal R, Carmichael B. Idiopathic retroperitoneal fibrosis: clinicopathologic features and outcome analysis. Clin Rheumatol. 2016;35:401–407.
   Google Scholar
• Scheel PJ Jr, Retroperitoneal Fibrosis: FN, Clinical T. Laboratory, and radiographic presentation. Medicine (Baltimore). 2009;88:202–207.
   Google Scholar
• Pelkmans LG, Aarnoudse AJ, Hendriksz TR, et al. Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis. Nephrol Dial Transplant. 2012;27:2819–2825.
   Google Scholar
• Vaglio A, Greco P, Corradi D, et al. Autoimmune aspects of chronic periaortitis. Autoimmun Rev. 2006;5:458–464.
   Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–551.
   Google Scholar
• Bakir B, Yilmaz F, Turkay R, et al. Role of diffusion-weighted MR imaging in the differentiation of benign retroperitoneal fibrosis from malignant neoplasm: preliminary study. Radiology. 2014;272:438–445.
   Google Scholar
• Fraum TJ, Ludwig TR, Bashir MR, et al. Gadolinium-based contrast agents: a comprehensive risk assessment. J Magn Res Imaging. 2017;46:338–353.
   Google Scholar
• Mirault T, Lambert M, Puech P, et al. Malignant retroperitoneal fibrosis: MRI characteristics in 50 patients. Medicine (Baltimore). 2012;91:242–250.
   Google Scholar
• Vaglio A, Versari A, Fraternali A, et al. (18)F-fluorodeoxyglucose positron emission tomography in the diagnosis and followup of idiopathic retroperitoneal fibrosis. Arthritis Rheum. 2005;53:122–125.
   Google Scholar
• Urban ML, Nicastro M, Corradi D, et al. Idiopathic and secondary forms of retroperitoneal fibrosis: a diagnostic approach. Rev Méd Int. 2015;36:15–21.
   Google Scholar
• Bombardieri M, Lewis M, Pitzalis C. Ectopic lymphoid neogenesis in rheumatic autoimmune diseases. Nat Rev Rheumatol. 2017;13:141–154.
   Google Scholar
• Umehara H, Okazaki K, Masaki Y, et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD) 2011. Mod Rheumatol. 2012;22:21–30.
   Google Scholar
• Castelein T, Coudyzer W, Blockmans D. IgG4-related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4-related periaortitis? Rheumatology. 2015;54:1250–1256.
   Google Scholar
• Runowska M, Majewski D, Puszczewicz M. Retroperitoneal fibrosis – the state-of-the-art. Reumatologia. 2016;54:256–263.
   Google Scholar
• van Bommel EF, Siemes C, Hak LE, et al. Long-term renal and patient outcome in idiopathic retroperitoneal fibrosis treated with prednisone. Am J Kidney Dis. 2007;49:615–625.
   Google Scholar
• van Bommel EF, Pelkmans LG, van Damme H, et al. Long-term safety and efficacy of a tamoxifen-based treatment strategy for idiopathic retroperitoneal fibrosis. Eur J Intern Med. 2013;24:444–450.
   Google Scholar
• Vaglio A, Palmisano A, Alberici F, et al. Prednisone versus tamoxifen in patients with idiopathic retroperitoneal fibrosis: an open-label randomised controlled trial. Lancet. 2011;378:338–346.
   Google Scholar
• van der Bilt FE, Hendriksz TR, van der Meijden WA, et al. Outcome in patients with idiopathic retroperitoneal fibrosis treated with corticosteroid or tamoxifen monotherapy. Clin Kidney J. 2016;9:184–191.
   Google Scholar
• Maritati F, Corradi D, Versari A, et al. Rituximab therapy for chronic periaortitis. Ann Rheum Dis. 2012;71:1262–1264.
   Google Scholar
• Catanoso MG, Spaggiari L, Magnani L, et al. Efficacy of infliximab in a patient with refractory idiopathic retroperitoneal brosis. Clin Exp Rheumatol. 2012;30:776–778.
   Google Scholar
• Vaglio A, Catanoso MG, Spaggiari L, et al. Interleukin-6 as an inflammatory mediator and target of therapy in chronic periaortitis. Arthritis Rheum. 2013;65:2469–2475.
   Google Scholar
• Kermani T, Crowson C, Achenbach S, et al. Idiopathic retroperitoneal fibrosis: a retrospective review of clinical presentation, treatment, and outcomes. Mayo Clin Proc. 2011;86:297–303.
   Google Scholar